Hydroxy Itraconazole - CAS 112559-91-8
Catalog number:
112559-91-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C35H38Cl2N8O5
Molecular Weight:
721.65
COA:
Inquire
Targets:
Others
Description:
Hydroxy Itraconazole, a metabolite of Itraconazole, is a ketoconazole analogue which could be used as an antimycotic.
Publictions citing BOC Sciences Products
  • >> More
Purity:
> 95%
Appearance:
Off-White Solid
Synonyms:
4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-methylpropyl)-3H-1,2,4-triazol-3-one;
Solubility:
10 mM in DMSO
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
Hydroxy Itraconazole is a metabolite of Itraconazole and could be used as an antimycotic.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
Melting Point:
91-96°C
InChIKey:
ISJVOEOJQLKSJU-UHFFFAOYSA-N
InChI:
InChI=1S/C35H38Cl2N8O5/c1-24(25(2)46)45-34(47)44(23-40-45)29-6-4-27(5-7-29)41-13-15-42(16-14-41)28-8-10-30(11-9-28)48-18-31-19-49-35(50-31,20-43-22-38-21-39-43)32-12-3-26(36)17-33(32)37/h3-12,17,21-25,31,46H,13-16,18-20H2,1-2H3
Canonical SMILES:
CC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
1.Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters.
Vermeer LM1, Isringhausen CD1, Ogilvie BW1, Buckley DB2. Drug Metab Dispos. 2016 Mar;44(3):453-9. doi: 10.1124/dmd.115.067744. Epub 2015 Dec 14.
Ketoconazole is a potent CYP3A4/5 inhibitor and, until recently, recommended by the Food and Drug Administration (FDA) and the European Medicines Agency as a strong CYP3A4/5 inhibitor in clinical drug-drug interaction (DDI) studies. Ketoconazole sporadically causes liver injury or adrenal insufficiency. Because of this, the FDA and European Medicines Agency recommended suspension of ketoconazole use in DDI studies in 2013. The FDA specifically recommended use of clarithromycin or itraconazole as alternative strong CYP3A4/5 inhibitors in clinical DDI studies, but many investigators have also used ritonavir as an alternative. Although the effects of these clinical CYP3A4/5 inhibitors on other CYPs are largely established, reports on the effects on the broad range of drug transporter activities are sparse. In this study, the inhibitory effects of ketoconazole, clarithromycin, ritonavir, and itraconazole (and its CYP3A4-inhibitory metabolites, hydroxy-, keto-, and N-desalkyl itraconazole) toward 13 drug transporters (OATP1B1, OATP1B3, OAT1, OAT3, OCT1, OCT2, MATE1, MATE2-K, P-gp, BCRP, MRP2, MRP3, and BSEP) were systematically assessed in transporter-expressing HEK-293 cell lines or membrane vesicles.
2.Simultaneous determination of itraconazole, hydroxy itraconazole, keto itraconazole and N-desalkyl itraconazole concentration in human plasma using liquid chromatography with tandem mass spectrometry.
Liang X1, Van Parys M2, Ding X3, Zeng N4, Bi L4, Dorshort D2, McKnight J2, Milanowski D2, Mao J3, Chen Y3, Ware JA5, Dean B3, Hop CE3, Deng Y3. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 May 1;1020:111-9. doi: 10.1016/j.jchromb.2016.03.039. Epub 2016 Mar 26.
A high-performance liquid chromatography tandem mass spectrometry (LC-MS/MS) assay was developed and validated for simultaneous determination of itraconazole (ITZ), hydroxy-itraconazole (OH-ITZ), keto-itraconazole (keto-ITZ) and N-desalkyl itraconazole (ND-ITZ) concentration in human plasma. One hundred and fifty microliters of human plasma were extracted using a solid-supported liquid extraction (SLE) method and the final extracts were analyzed using reverse-phase chromatography and positive electrospray ionization mass spectrometry. The standard curve range is 5-2500 ng/mL for ITZ and OH-ITZ and 0.4-200ng/mL for keto-ITZ and ND-ITZ. The curve was fitted to a 1/x(2) weighted linear regression model for all analytes. The precision and accuracy of the LC-MS/MS assay based on the five analytical quality control (QC) levels were well within the acceptance criteria from both FDA and EMA guidance for bioanalytical method validation. Average extraction recovery was 97.
3.A model for treating avian aspergillosis: serum and lung tissue kinetics for Japanese quail (Coturnix japonica) following single and multiple aerosol exposures of a nanoparticulate itraconazole suspension.
Rundfeldt C1, Wyska E, Steckel H, Witkowski A, Jeżewska-Witkowska G, Wlaź P. Med Mycol. 2013 Nov;51(8):800-10. doi: 10.3109/13693786.2013.803166. Epub 2013 Jul 2.
Aspergillosis is frequently reported in parrots, falcons and other birds held in captivity. Inhalation is the main route of infection for Aspergillus fumigatus, resulting in both acute and chronic disease conditions. Itraconazole (ITRA) is an antifungal commonly used in birds, but administration requires repeated oral dosing and the safety margin is narrow. We describe lung tissue and serum pharmacokinetics of a nanoparticulate ITRA suspension administered to Japanese quail by aerosol exposure. Aerosolized ITRA (1 and 10% suspension) administered over 30 min did not induce adverse clinical reactions in quail upon single or 5-day repeated doses. High lung concentrations, well above the inhibitory levels for A. fumigatus, of 4.14 ± 0.19 μg/g and 27.5 ± 4.58 μg/g (mean ± SEM, n = 3), were achieved following single-dose inhalation of 1% and 10% suspension, respectively. Upon multiple dose administration of 10% suspension, mean lung concentrations reached 104.
4.Evaluation of Antifungal Activity and Mode of Action of New Coumarin Derivative, 7-Hydroxy-6-nitro-2H-1-benzopyran-2-one, against Aspergillus spp.
Guerra FQ1, de Araújo RS2, de Sousa JP1, Pereira Fde O3, Mendonça-Junior FJ2, Barbosa-Filho JM2, de Oliveira Lima E1. Evid Based Complement Alternat Med. 2015;2015:925096. doi: 10.1155/2015/925096. Epub 2015 Jun 14.
Aspergillus spp. produce a wide variety of diseases. For the treatment of such infections, the azoles and Amphotericin B are used in various formulations. The treatment of fungal diseases is often ineffective, because of increases in azole resistance and their several associated adverse effects. To overcome these problems, natural products and their derivatives are interesting alternatives. The aim of this study was to examine the effects of coumarin derivative, 7-hydroxy-6-nitro-2H-1-benzopyran-2-one (Cou-NO2), both alone and with antifungal drugs. Its mode of action against Aspergillus spp. Cou-NO2 was tested to evaluate its effects on mycelia growth and germination of fungal conidia of Aspergillus spp. We also investigated possible Cou-NO2 action on cell walls (0.8 M sorbitol) and on Cou-NO2 to ergosterol binding in the cell membrane. The study shows that Cou-NO2 is capable of inhibiting both the mycelia growth and germination of conidia for the species tested, and that its action affects the structure of the fungal cell wall.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 103-86-6 4-(2-aminopropyl)phenol

4-(2-aminopropyl)phenol
(CAS: 103-86-6)

Hydroxyamphetamine, an active metabolite product of amphetamine, is a prescription drug that could stimulate the sympathetic nervous system and commonly be used...

CAS 1323403-33-3 Iberdomide

Iberdomide
(CAS: 1323403-33-3)

Iberdomide, also known as CC-220, is a modulator of cereblon potentially for the treatment of systemic lupus erythematosus. Iberdomide exhibits an IC50 of 60 nM...

CAS 111-48-8 Thiodiglycol

Thiodiglycol
(CAS: 111-48-8)

Thiodiglycol, the hydrolysis product of sulfur mustard, is useful in textile dyeing and sorts of pen ink manufacturing. It could produce mustard gas reacted wit...

CAS 58-27-5 Menadione

Menadione
(CAS: 58-27-5)

Menadione shows vitamin K activity, used as a nutritional supplement.

CAS 100-55-0 3-(Hydroxymethyl)pyridine

3-(Hydroxymethyl)pyridine
(CAS: 100-55-0)

3-Pyridinemethanol, an aromatic alcohol compound, is a widely used in the synthesis of some inhibitors like Chk1 and histone deacetylase inhibitors.

CAS 1256094-72-0 AI-10-49

AI-10-49
(CAS: 1256094-72-0)

AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBFβ-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM.

CAS 29908-03-0 Ademetionine

Ademetionine
(CAS: 29908-03-0)

S-adenosyl-l-methionine (SAMe) is a naturally-occurring substance which is a major source of methyl groups in the brain. The efficacy of SAMe in treating depres...

CAS 7432-28-2 Schisandrin

Schisandrin
(CAS: 7432-28-2)

Schisandrin has various therapeutic effects on a range of medical conditions such as anti-asthmatic, anti-cancer, and anti-inflammatory effects.

CAS 538-71-6 Domiphen Bromide

Domiphen Bromide
(CAS: 538-71-6)

Domiphen bromide is a quaternary ammonium antiseptic with actions as a cationic surfactant.

CAS 72103-53-8 Tuftsin diacetate

Tuftsin diacetate
(CAS: 72103-53-8)

Tuftsin diacetate is a macrophage/microglial activator.

SPDB
(CAS: 115088-06-7)

SPDB, a pyridyldithioyl compound, has been found to link to DM4 conjugates and probably influence the releasement of cytotoxic metabolitesin.

CAS 6902-77-8 Genipin

Genipin
(CAS: 6902-77-8)

Genipin, a compound isolated from Gardenis jasminoides Ellis fruits, is a cell-permeable inhibitor of UCP2 activity. Genipin also exhibits anti-inflammatory and...

CAS 137-58-6 Lidocaine

Lidocaine
(CAS: 137-58-6)

Lidocaine is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 μM.

CAS 341-69-5 Orphenadrine hydrochloride

Orphenadrine hydrochloride
(CAS: 341-69-5)

A skeletal muscle relaxant used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.

CAS 97145-43-2 Kallikrein Inhibitor

Kallikrein Inhibitor
(CAS: 97145-43-2)

Kallikrein Inhibitor, a synthetic peptide, is a serine protease inhibitor that inhibits kallikrein and plasmin, and can attenuate breast cancer cell invasion.

CAS 20537-88-6 Amifostine

Amifostine
(CAS: 20537-88-6)

Amifostine is a phosphorylated aminosulfhydryl compound. After dephosphorylation of amifostine by alkaline phosphatase to an active free sulfhydryl (thiol) meta...

AMZ30
(CAS: 1313613-09-0)

AMZ30, a PME-1 inhibitor, could inhibit PME-1 irreversiblely and be significant in the pharmacological study of determinating the demethylated PP2A function. IC...

CAS 633-65-8 Berberine HCl

Berberine HCl
(CAS: 633-65-8)

Berberine HCl is a quaternary ammonium salt from the group of isoquinoline alkaloids.

CAS 256414-75-2 SEW 2871

SEW 2871
(CAS: 256414-75-2)

SEW 2871 is a potent, cell-permeable and selective sphingosine-1-phosphate type 1 receptor agonist (EC50= 13 nM). SEW 2871 suppresses the immune response by dec...

CAS 119302-91-9 Rocuronium Bromide

Rocuronium Bromide
(CAS: 119302-91-9)

Rocuronium Bromide is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant.

Chemical Structure

CAS 112559-91-8 Hydroxy Itraconazole

Quick Inquiry

Verification code

Featured Items